| 摘要 |
The present invention provides a compound, or a salt thereof, indicated by formula (1) [in the formula, Xa and Ya indicate a single bond, etc., the cancer antigen peptide A indicates a MHC class I binding cancer antigen peptide, R1 indicates a hydrogen atom, a group indicated by formula (2) (in the formula, Xb and Yb indicate a single bond, etc., and the cancer antigen peptide B indicates a MHC class I or II binding cancer antigen peptide that is different from the cancer antigen peptide A), a group indicated by formula (3) (in the formula Xc and Yc indicate a single bond, etc., and the cancer antigen peptide C indicates an MHC class II binding cancer antigen peptide), or a cancer antigen peptide D, and cancer antigen peptide D indicates a MHC class I or Class II binding cancer antigen peptide including one cysteine residue.] |
